Skip to main navigation Skip to search Skip to main content

273rd ENMC International workshop: Clinico-Sero-morphological classification of the Antisynthetase syndrome. Amsterdam, The Netherlands, 27-29 October 2023

  • ENMC Antisynthetase Syndrome Study Group
  • Charité-Universitätsmedizin Berlin
  • Foundation for Advanced Education in the Sciences at the NIH
  • Hospices Civils de Lyon
  • University Medical Center Hamburg-Eppendorf
  • Service de Médecine Physique et Réadaptation
  • Maastricht University Medical Center (MUMC+)
  • Johns Hopkins University School of Medicine
  • Copenhagen University Hospital
  • Stanford University School of Medicine
  • Hopitaux Universitaires Strasbourg
  • Patient representative
  • Karolinska Institutet
  • Düsseldorf University Hospital
  • University of Bath, Department of Life Sciences
  • University Paris 13

Research output: Contribution to journal › Article › peer-review

35 Citations (Scopus)

Abstract

Among the idiopathic inflammatory myopathies, patients harbouring an Antisynthetase syndrome exhibit a unique clinical picture, with characteristic signs such as myositis, interstitial lung disease, arthritis, rash, and/or fever. Characteristic morphological features on skeletal muscle biopsies differentiate Antisynthetase syndrome from other forms of myositis. Autoantibodies typically recognizing one of the members of the aminoacyl-tRNA synthetase family of proteins can be detected in the serum of such patients, with anti-Jo1 being most frequent. Until now, an international consensus definition of the Antisynthetase syndrome is lacking, hence this workshop has undertaken the task to inform about the clinical, morphological and autoantibody profiles of Antisynthetase syndrome. The authors also expand their aims by giving management and therapeutic strategies, and finally provide precise classification criteria for Antisynthetase syndrome.

Original languageEnglish
Article number104453
JournalNeuromuscular Disorders
Volume45
DOIs
Publication statusPublished - Dec 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anti-synthetase syndrome
  • Idiopathic inflammatory myopathies
  • tRNA synthetase autoantibodies, ILD, arthritis

Fingerprint

Dive into the research topics of '273rd ENMC International workshop: Clinico-Sero-morphological classification of the Antisynthetase syndrome. Amsterdam, The Netherlands, 27-29 October 2023'. Together they form a unique fingerprint.

Cite this